hearing loss Archives

Home hearing loss

Latest Posts

Best in Biotech 23 Mar 2023

Hearing loss research: Five advancements in the past year

At present, more than 1.4 billion people live with hearing loss globally. Hearing disorders are often caused by aging, frequent exposure to loud noises and even hereditary factors. In this…

March 23, 2023 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 Aug 2023

Five North Carolina biotech companies making their mark

North Carolina is home to Research Triangle Park, an R&D sanctuary situated between the cities of Raleigh and Durham, which just happens to be one of the biggest biotech hubs…

August 30, 2023 - 5 minutesmins - By Willow Shah-Neville

News and Trends 6 Jul 2023

Positive data from Sensorion hearing loss study

Sensorion, which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has reported further analysis from its Proof of Concept…

July 6, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 9 May 2023

The future of cell and gene therapy in hearing loss

By Nawal Ouzren, CEO of Sensorion Therapeutics for inner ear hearing loss remains an unconquered frontier and the unmet need is vast. Hearing loss is predicted to affect nearly 2.5…

May 9, 2023 - 3 minutesmins - By External Contributor

Best in Biotech 29 Mar 2023

5 hearing loss biotech companies you should know about

More than 1.5 billion people - nearly 20% of the world’s population - live with hearing loss globally, with 430 million suffering from disabling hearing loss. In this article, we…

March 29, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 28 Mar 2023

Stem cell therapy: a potential cure for hearing loss?

The dawn of the 21st century witnessed the success of the Human Genome Project, the quiver of the Braille glove and the ease of obtaining both an ancestry profile and…

March 28, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 22 Jul 2022

Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma

On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach, and Eric Moessinger, both partners at +ND Capital; and Louise Modis, chief scientific officer at…

July 22, 2022 - 7 minutesmins - By Jim Cornall

News and Trends 31 Jan 2023

Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments

Sensorion and EVEON are collaborating on the design and development of an injection system for the delivery of Sensorion’s gen therapy products to the inner ear. Therapies for treating genetic…

January 31, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 Jan 2023

Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial

Sensorion has announced that the first patient has been enrolled in its phase 2a proof of concept clinical trial of SENS-401 (Arazasetron) in patients suffering from cisplatin-induced ototoxicity. Cisplatin and…

January 3, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 5 Jul 2022

Mogrify and Astellas to address sensorineural hearing loss

Biopharma company Mogrify Limited, and Japanese regenerative medicine firm Astellas Pharma Inc., have announced a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss. Utilizing…

July 5, 2022 - 2 minutesmins - By Jim Cornall

More News! 7 Nov 2022

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

Sensorion has announced that the US Food and Drug Administration (FDA) has granted rare pediatric disease designation to its lead therapy gene candidate, OTOF-GT. The gene therapy is intended for…

November 7, 2022 - 2 minutesmins - By Liza Laws

More News! 24 Oct 2022

Sensorion gets go-ahead from France for trial of drug to prevent hearing loss

Biotech company, Sensorion, today (October 24) announced that the initiation of a proof of concept (PoC) clinical trial of SENS-401 (Arazasetron) in patients with Cisplatin-Induced Ototoxicity (CIO) has been approved…

October 24, 2022 - 3 minutesmins - By Liza Laws

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering